David Goeddel is a Managing Partner at The Column Group, whose known portfolio counts 9 companies.
Is David Goeddel a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell TherapyDrug DiscoveryGeneticsGenomicsLife SciencePharmaSmall MoleculesTherapeutics
Contacts
Affiliated funds' portfolios
Managing Partner at The Column Group, whose known portfolio counts 9 companies
- Neurona Therapeutics
- Atavistik Bio
- Eikon Therapeutics
- Rapt Therapeutics
- TR1X
- Tortugas Neuroscience
- NILO Therapeutics
- Surrozen
- A2 Biotherapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Cell Therapy, Drug Discovery and Genetics. Startups operating in these areas may find David Goeddel relevant.
Stage-wise, the deals at The Column Group cluster around Growth, Late-Stage and Seed rounds.
The firm portfolio and the focus above give founders context on whether David Goeddel matches their raise.
Colleagues at The Column Group
Larry Lasky
Investor
Sausalito, United States
Jeff Goater
Partner
Boston, United States
Carla Daniel
Partner & Chief People Officer
San Francisco, United States
Leon Chen
Partner
Palo Alto, United States
Sarah Hymowitz
Partner
San Francisco, United States
John Josey
Partner
Dallas, United States
Michael Rape
iPartner
San Francisco, United States
Tim Kutzkey
Managing Partner
San Francisco, United States
Hui Tian
Partner
San Mateo, United States
Peter Svennilson
Managing Partner & Founder
San Francisco, United States
Millie Ray
Partner
United States
David Goeddel
Managing Partner
Burlingame, United States
Frequently asked questions
Who is David Goeddel?
David Goeddel is a venture capital investor based in Burlingame, California, United States, listed as Managing Partner at The Column Group. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to David Goeddel personally.
What does David Goeddel invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Drug Discovery and Genetics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does David Goeddel invest at?
The Column Group appears in Growth, Late-Stage and Seed rounds across its known deals, and David Goeddel is listed there as Managing Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is David Goeddel listed at?
David Goeddel is listed as Managing Partner at The Column Group. 12 other people in the database share a firm with David Goeddel.
How do I contact David Goeddel?
An email address, a phone number and a LinkedIn page are on file for David Goeddel. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal